The persistent challenge of peanut allergies, which has plagued allergy sufferers and scientists for decades, may soon see a transformative…
Read More

The persistent challenge of peanut allergies, which has plagued allergy sufferers and scientists for decades, may soon see a transformative…
Read More
Novartis has entered into a definitive agreement to acquire Excellergy, a privately held biotechnology company specializing in the development of…
Read More